Featured Research

from universities, journals, and other organizations

Gene Therapy: Identifying Where Genes Can Successfully Integrate

Date:
August 6, 2007
Source:
Journal of Clinical Investigation
Summary:
Gene therapy -- whereby a retrovirus that integrates into the genome of a treated patient is used to deliver the gene of interest -- has been used to treat some individuals with inherited diseases such as X-linked SCID, a disease that causes widespread immunosuppression and therefore susceptibility to infection. However, a small number of the treated individuals developed leukemia-like diseases because the retrovirus integrated into the genome at a site(s) that caused the cells to divide uncontrollably.

Gene therapy -- whereby a retrovirus that integrates into the genome of a treated patient is used to deliver the gene of interest -- has been used to treat some individuals with inherited diseases such as X-linked SCID, a disease that causes widespread immunosuppression and therefore susceptibility to infection.

However, a small number of the treated individuals developed leukemia-like diseases because the retrovirus integrated into the genome at a site(s) that caused the cells to divide uncontrollably.

Analysis of the sites of retroviral integration in individuals treated with gene therapy is therefore of utmost importance to the further development of such gene therapy approaches and three studies that appear in the August issue of the Journal of Clinical Investigation address this issue.

The three studies -- reported by researchers from the National Center for Tumor Diseases, Heidelberg, Germany; University College London, London, United Kingdom; and the San Raffaele Telethon Institute for Gene Therapy, Milan, Italy -- indicate that the retroviruses used to deliver the genes of interest in these studies, gammaretroviruses, integrated near the 5" ends of genes that are active in the treated cell population.

Although the diversity of the detected retroviral integration sites decreased following transplantation into patients because the treated cells differentiated, the sites detected remained at the 5" end of genes active in the cell populations analyzed. Importantly, the retrovirus integration sites observed in cells from successfully treated patients were not significantly different from those observed in cells from patients that went on to develop leukemia-like disease.

As discussed in the accompanying commentary by Frederic Bushman from the University of Pennsylvania, Philadelphia, these studies are critical if researchers are to determine whether the dangers of retroviral gene therapy can be predicted and/or eliminated.


Story Source:

The above story is based on materials provided by Journal of Clinical Investigation. Note: Materials may be edited for content and length.


Cite This Page:

Journal of Clinical Investigation. "Gene Therapy: Identifying Where Genes Can Successfully Integrate." ScienceDaily. ScienceDaily, 6 August 2007. <www.sciencedaily.com/releases/2007/08/070802211036.htm>.
Journal of Clinical Investigation. (2007, August 6). Gene Therapy: Identifying Where Genes Can Successfully Integrate. ScienceDaily. Retrieved September 22, 2014 from www.sciencedaily.com/releases/2007/08/070802211036.htm
Journal of Clinical Investigation. "Gene Therapy: Identifying Where Genes Can Successfully Integrate." ScienceDaily. www.sciencedaily.com/releases/2007/08/070802211036.htm (accessed September 22, 2014).

Share This



More Health & Medicine News

Monday, September 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Sierra Leone in Lockdown to Control Ebola

Sierra Leone in Lockdown to Control Ebola

AP (Sep. 21, 2014) Sierra Leone residents remained in lockdown on Saturday as part of a massive effort to confine millions of people to their homes in a bid to stem the biggest Ebola outbreak in history. (Sept. 20) Video provided by AP
Powered by NewsLook.com
Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com
Changes Found In Brain After One Dose Of Antidepressants

Changes Found In Brain After One Dose Of Antidepressants

Newsy (Sep. 19, 2014) A study suggest antidepressants can kick in much sooner than previously thought. Video provided by Newsy
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins